ACCP Virtual Poster Symposium (May 22-24, 2012): Scientific Poster Symposium Session 3 -- Original Research

4E

Evaluation and ranking of consumer health and drug information smartphone applications

Amy M. Pope, Pharm.D.¹, Patrick J Bryant, Pharm.D., FSCIP², Heather A Pace, Pharm.D.² and Morgan L Sperry, Pharm.D.²
1University of Missouri-Kansas City School of Pharmacy Drug Information Center, Kansas City, MO
2University of Missouri- Kansas City School of Pharmacy Drug Information Center, Kansas city, MO

PDF file

6

Long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients

Kathryn Elofson, PharmD, Sarah Girardot, PharmD, Andrew Tang, MD, Joshua Gaither, MD and Asad E. Patanwala, PharmD
University of Arizona, Tucson, AZ

PDF file

9

Risk factors for clinical failure in patients hospitalized with cellulitis/cutaneous abscess

Jenana Halilovic, PharmD, BCPS, AAHIVP¹, Brett Heintz, PharmD, BCPS-ID, AAHIVE² and Jennifer Brown, MD²
1University of the Pacific TJL School of Pharmacy and Health Sciences, Stockton, CA
2University of California, Davis Medical Center, Sacramento, CA

10E

Evaluation of the emetogenic potential of tigecycline 50mg twice daily versus 100mg once daily

Nehal G. Hashem, PharmD¹, Greg Mateyoke, PharmD¹, Meghna Vallabh, PharmD, BCPS¹, William R. Judd, Pharm.D., BCPS² and Mark Dougherty, MD³
1Saint Joseph East, Lexington, KY
2Saint Joseph Health System, Lexington, KY
3Lexington Infectious Disease Consultants, Lexington, KY

PDF file

15

Oxaliplatin for elderly patients: dosing regimens in a German secondary care hospital, safety and quality of life

Goentje-Gesine Marquardt, PhD¹, Klaus Meier, pharmacist¹ and Dorothee C. Dartsch, PhD, Prof.²
1Heidekreis Klinikum Soltau, Soltau, Germany
2Hamburg University, Hamburg, Germany

PDF file

18

Cost-effectiveness analysis of dexmedetomidine versus propofol for sedation in mechanically ventilated patients after cardiovascular surgery; an institutional perspective

Matthew Wanat, PharmD, BCPS, Kalliopi Fitousis, PharmD, BCPS, Fariedeh Bostan, PharmD and Faisal Masud, MD, FCCP
The Methodist Hospital, Houston, TX

PDF file

19

Rural Patient's Willingness to Use Mobile Phone Technologies for Accessing Pharmacy Services

Jayashri Sankaranarayanan, M.Pharm., Ph.D. and Rory E. Sallach, Pharm.D., Candidate
University of Nebraska Medical Center College of Pharmacy, Omaha, NE

PDF file

22

Impact of CYP2C19*2 loss-of-function polymorphisms on platelet reactivity after loading dose of clopidogrel in healthy Malaysian volunteers

Yanti N. Sani, Bachelor, Pharmacy¹, Sheau C. Lim, Master, Science¹, Luen H. Lim, Bachelor, Science¹, Elyana Y. Edwin, Bachelor, Pharmacy¹, Nurzalina A.K. Khan, PhD¹, Teck H. Goh, MD², Victor L. Serebruany, MD, PhD³ and Kah H. Yuen, PhD¹
1School of Pharmaceutical Sciences, Penang, Malaysia
2Loh Guan Lye Hospital, Penang, Malaysia
3John Hopkins University, Towson, MD

31E

Long-term safety of budesonide/formoterol pressurized metered-dose inhaler and budesonide pressurized metered-dose inhaler in African-American patients with asthma: asthma exacerbations and adverse events

Randall W. Brown, MD, MPH¹, Tom Uryniak, MS² and Kathy L. Lampl, MD²
1Center for Managing Chronic Disease, University of Michigan, Ann Arbor, MI
2AstraZeneca LP, Wilmington, DE

32E

Adverse events in patients with blood loss: a pooled analysis of 51 clinical studies from the celecoxib clinical trial database

George H. Sands, MD, Briton Shell, PhD and Richard Y. Zhang, PhD
Pfizer Inc, New York, NY

PDF file

33

Response to nonsteroidal anti-inflammatory drugs in African American subjects with osteoarthritis of the knee

Margaret Noyes Essex, Pharm.D., Michael A. O'Connell, M.D. and Pritha Bhadra, PhD
Pfizer Inc, New York, NY

PDF file

34E

Pathways to prescription opioid addiction

Beth A. Sproule, BScPhm, PharmD¹ and Bruna Brands, PhD²
1Centre for Addiction and Mental Health and University of Toronto, Toronto, ON, Canada
2Health Canada and University of Toronto, Toronto, ON, Canada

PDF file